Mandate

Vinge advises Industrifonden in connection with an investment in Cellevate

July 03, 2023 M&A

Vinge has advised Industrifonden in connection with its investment in Cellevate. Cellevate is an innovative biotech company that develops the next generation of cell culture systems.

Vinge’s team primarily consisted of Johan Larsson, Ellinor Wargenbrant and Stojan Arnerstål

Related

Vinge advises TSG on the acquisition of Processkontroll GT

TSG, a European leader in technical services for sustainable mobility solutions and critical energy infrastructure, has acquired Processkontroll GT, a specialist in compressed and liquid gas infrastructure.
June 01, 2026

Vinge has advised Nordion Energi AB in connection with the acquisition of shares in Kalmar Energi

Nordion Energi acquires E.ON Sverige AB’s entire stake in Kalmar Energi and in connection with the completion of such, divest Kalmar Energi’s electricity retail business to Siljansvik AB (publ).
May 29, 2026

Vinge advises Latour on the sale of shares in ASSA ABLOY and Securitas, amounting to SEK 2.5 billion in each company

Vinge has advised Investmentaktiebolaget Latour (publ) in connection with the sale of parts of its shareholdings in ASSA ABLOY and Securitas for a total value of SEK 5 billion.
May 27, 2026